NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock
NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3080% below fair value
$0.71−0.04 (-5.15%)
Close on Nov 17, 2026Market cap $6.43MP/E –Yield –
Neuroone Medical Technologies operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Neuroone Medical Technologies's operating income for the twelve months ending Jun 30, 2026 was -$7.90M. For fiscal 2025 it was -$4.23M. The highest annual figure on record is -$13.73K in fiscal 2012.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$4.23M | – |
| FY2024 | Sep 30, 2024 | -$11.89M | – |
| FY2023 | Sep 30, 2023 | -$11.96M | – |
| FY2022 | Sep 30, 2022 | -$10.03M | – |
| FY2021 | Sep 30, 2021 | -$10.22M | – |
| FY2020 | Sep 30, 2020 | -$4.90M | – |
| FY2017 | Dec 31, 2017 | -$3.07M | – |
| FY2016 | Dec 31, 2016 | -$32.61K | – |
| FY2015 | Dec 31, 2015 | -$30.92K | – |
| FY2014 | Dec 31, 2014 | -$35.91K | – |
| FY2013 | Dec 31, 2013 | -$25.09K | – |
| FY2012 | Dec 31, 2012 | -$13.73K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | -$2.42M | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | -$2.40M | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -$1.71M | -199.8% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | -$1.37M | – |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | -$1.89M | – |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | -$2.68M | – |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $1.71M | – |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | -$2.82M | – |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | -$2.79M | – |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | -$2.89M | – |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | -$3.39M | – |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | -$3.16M | – |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | -$3.51M | – |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | -$3.50M | – |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | -$1.78M | – |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | -$1.40M | – |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | -$2.76M | – |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | -$3.06M | – |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | -$2.81M | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -$2.64M | – |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | -$3.03M | – |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | -$2.40M | – |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | -$2.14M | – |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | -$117.43K | – |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | -$1.59M | – |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | -$1.38M | – |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | -$1.81M | – |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | -$773.78K | – |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | -$893.79K | – |
| Q2 FY2017CQ2 2017 | Jun 30, 2017 | -$888.69K | – |
| Q1 FY2017CQ1 2017 | Mar 31, 2017 | -$516.06K | – |
| Q4 FY2016CQ4 2016 | Dec 31, 2016 | -$65.67K | – |
| Q3 FY2016CQ3 2016 | Sep 30, 2016 | -$8.60K | – |
| Q2 FY2016CQ2 2016 | Jun 30, 2016 | -$14.11K | – |
| Q1 FY2016CQ1 2016 | Mar 31, 2016 | -$4.39K | – |
| Q4 FY2015CQ4 2015 | Dec 31, 2015 | -$8.83K | – |
| Q3 FY2015CQ3 2015 | Sep 30, 2015 | -$2.59K | – |
| Q2 FY2015CQ2 2015 | Jun 30, 2015 | -$18.67K | – |
| Q1 FY2015CQ1 2015 | Mar 31, 2015 | -$1.83K | – |
| Q4 FY2014CQ4 2014 | Dec 31, 2014 | -$9.88K | – |
See a number that looks wrong?